PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2)
2011-04-01 Yuan-Hao Hsu   AffiliationDepartment of Chemistry, Biochemistry, Pharmacology, School of Medicine, San Diego, La Jolla, California 92093-0601, USA
DNA/RNA
Description
Pak2 gene at 193763319 to 193859670 bp from pter contains 96352 bases and 34 exons. Pak2 gene at the alternative location starts at 196466728 and ends at 196559518 bp from pter. The PAK2 gene in this location contains 20 exons.
Proteins

The Linear schematic of Pak2. Functional domains, including proline rich regions (P), acidic region (A), p21-binding domain (PBD), Cdc42 and Rac interaction and binding sequence (CRIB) and autoinhibitory domain (AID) are designated. Autophosphorylation sites (*) and caspase 3 cleavage site (v) are marked. The regulatory domain is blue; the protein kinase domain is green; the overlapping region between PBD and AID is pink.
Description
Pak2 has an N-terminal regulatory domain and a C-terminal catalytic domain. In the regulatory domain, Pak2 have several conserved regions, including an autoinhibitory domain (AID), a p21-binding domain (PBD), dimerization domain, proline-rich regions, and an acidic region. The schematic structure of Pak2 is shown in figure above. The catalytic domain of Pak is a conserved bilobal structure in most of the protein kinases.
Expression
Pak2 is 58.8 kDa (524 residues) and expressed ubiquitously in mammalian cells.
Function
PAK activation is through disruption of autoinhibition, followed by autophosphorylation. In the inactive state, the AID interacts with the catalytic domain to inhibit its kinase activity. GTP-bound Cdc42 can disrupt autoinhibition, which, in turn, leads to autophosphorylation and activation of PAK. Pak2s basal autophosphorylation activity is observed and Pak2 is autophosphorylated at 5 sites, serines 19, 20, 55, 192 and 197. Additional three phosphorylation sites (serines 141 and 165 and threonine 402) are autophosphorylated in the presence of Cdc42(GTP) and ATP. Autophosphorylation of Thr402 in the activation loop is required for the kinase activity of Pak2.
Pak2 can be activated in response to a lot of stresses. Moderate stresses, like hyperosmolarity, ionizing radiation, DNA-damaging agents and serum-deprivation, induce Pak2 activation in cells and lead to cell cycle arrest at G2/M. Activated Pak2 inhibits translation by phosphorylation of various substrates. Pak2 has specific protein substrates, e.g. histone 4, myosin light chain (MLC), prolactin, c-Abl, eukaryote translation initiation factor 3 (eIF3), eIF4B, eIF4G, and Mnk1. Pak2 recognizes the consensus sequence (K/RRXS).
Pak2 is the only member of the PAK family that is directly activated by caspase 3. When Pak2 is cleaved and activated by caspase 3, Pak2 promotes the morphological and biochemical changes of apoptosis. The pro-apoptosis protease, caspase 3 cleaves Pak2 after Asp 212, and thus produces a p27 fragment containing primarily the regulatory domain, and a p34 fragment containing a small piece of the regulatory domain and the entire catalytic domain. Autophosphorylation results in a constitutively active p34 kinase domain. The nuclear import signal (245-251) is required for nuclear localization. Disruption of the region (197-246), containing nuclear export signal results in the nuclear localization of the Pak2 p34 fragment.
Pak2 can be activated in response to a lot of stresses. Moderate stresses, like hyperosmolarity, ionizing radiation, DNA-damaging agents and serum-deprivation, induce Pak2 activation in cells and lead to cell cycle arrest at G2/M. Activated Pak2 inhibits translation by phosphorylation of various substrates. Pak2 has specific protein substrates, e.g. histone 4, myosin light chain (MLC), prolactin, c-Abl, eukaryote translation initiation factor 3 (eIF3), eIF4B, eIF4G, and Mnk1. Pak2 recognizes the consensus sequence (K/RRXS).
Pak2 is the only member of the PAK family that is directly activated by caspase 3. When Pak2 is cleaved and activated by caspase 3, Pak2 promotes the morphological and biochemical changes of apoptosis. The pro-apoptosis protease, caspase 3 cleaves Pak2 after Asp 212, and thus produces a p27 fragment containing primarily the regulatory domain, and a p34 fragment containing a small piece of the regulatory domain and the entire catalytic domain. Autophosphorylation results in a constitutively active p34 kinase domain. The nuclear import signal (245-251) is required for nuclear localization. Disruption of the region (197-246), containing nuclear export signal results in the nuclear localization of the Pak2 p34 fragment.
Mutations
Note
None is reported.
Implicated in
Entity name
Tumors
Prognosis
Huang (2004) showed Pak2 is a negative regulator of Myc and suggested Pak2 may be the product of a tumor suppressor gene. Coniglio (2008) reported Pak2 mediates tumor invasion in breast carcinoma cells. Inhibition of RhoA in Pak2-depleted cells decreases MLC phosphorylation and restores cell invasion. Also, the NF2 tumor suppressor Merlin is a substrate of Pak2. Wilkes (2009) showed that Erbin regulates the function of Merlin through Pak2 binding to Merlin.
Entity name
Immunodeficiency
Note
Human immunodeficiency virus type 1 HIV-1.
Prognosis
Human immunodeficiency virus type 1 Nef associates with a active Pak2 independently of binding to Nck or PIX. Nef recruits the GEF Vav1 to plasma membrane to associate with Pak2.
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 18411304 | 2008 | Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. | Coniglio SJ et al |
| 9774440 | 1998 | Differential effects of PAK1-activating mutations reveal activity-dependent and -independent effects on cytoskeletal regulation. | Frost JA et al |
| 10075701 | 1999 | Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation. | Gatti A et al |
| 18984590 | 2008 | Analysis of conformational changes during activation of protein kinase Pak2 by amide hydrogen/deuterium exchange. | Hsu YH et al |
| 20209159 | 2010 | Reciprocally coupled residues crucial for protein kinase Pak2 activity calculated by statistical coupling analysis. | Hsu YH et al |
| 14749374 | 2004 | Negative control of the Myc protein by the stress-responsive kinase Pak2. | Huang Z et al |
| 12853446 | 2003 | Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation. | Jakobi R et al |
| 11782491 | 2002 | Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. | Kissil JL et al |
| 9391079 | 1997 | Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. | Lee N et al |
| 16281055 | 2005 | Inhibition of cap-dependent translation via phosphorylation of eIF4G by protein kinase Pak2. | Ling J et al |
| 8107774 | 1994 | A brain serine/threonine protein kinase activated by Cdc42 and Rac1. | Manser E et al |
| 15234964 | 2004 | Phosphorylation of Mnk1 by caspase-activated Pak2/gamma-PAK inhibits phosphorylation and interaction of eIF4G with Mnk. | Orton KC et al |
| 11345898 | 2001 | Cytostatic p21 G protein-activated protein kinase gamma-PAK. | Roig J et al |
| 9171063 | 1997 | Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. | Rudel T et al |
| 9858584 | 1999 | Genetic evidence for Pak1 autoinhibition and its release by Cdc42. | Tu H et al |
| 9405039 | 1997 | Determinants for substrate phosphorylation by p21-activated protein kinase (gamma-PAK). | Tuazon PT et al |
| 9786869 | 1998 | Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity. | Walter BN et al |
| 19289088 | 2009 | Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta. | Wilkes MC et al |
| 9528787 | 1998 | A conserved negative regulatory region in alphaPAK: inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1. | Zhao ZS et al |
Other Information
Locus ID:
NCBI: 5062
MIM: 605022
HGNC: 8591
Ensembl: ENSG00000180370
Variants:
dbSNP: 5062
ClinVar: 5062
TCGA: ENSG00000180370
COSMIC: PAK2
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000180370 | ENST00000327134 | Q13177 |
| ENSG00000180370 | ENST00000426668 | H7C1X3 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37997254 | 2024 | A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas. | 1 |
| 38343537 | 2024 | Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2. | 6 |
| 38615921 | 2024 | ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription. | 0 |
| 37997254 | 2024 | A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas. | 1 |
| 38343537 | 2024 | Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2. | 6 |
| 38615921 | 2024 | ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription. | 0 |
| 36504449 | 2023 | Loss-of-Function of p21-Activated Kinase 2 Links BMP Signaling to Neural Tube Patterning Defects. | 2 |
| 36740679 | 2023 | Circular RNA 0001789 sponges miR-140-3p and regulates PAK2 to promote the progression of gastric cancer. | 4 |
| 37199682 | 2023 | Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation. | 0 |
| 36504449 | 2023 | Loss-of-Function of p21-Activated Kinase 2 Links BMP Signaling to Neural Tube Patterning Defects. | 2 |
| 36740679 | 2023 | Circular RNA 0001789 sponges miR-140-3p and regulates PAK2 to promote the progression of gastric cancer. | 4 |
| 37199682 | 2023 | Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation. | 0 |
| 34542739 | 2022 | miR-511-5p Suppresses Cell Migration, Invasion and Epithelial-Mesenchymal Transition Through Targeting PAK2 in Gastric Cancer. | 2 |
| 34750857 | 2022 | PAK1 and PAK2 in cell metabolism regulation. | 6 |
| 35082167 | 2022 | Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling. | 4 |
Citation
Yuan-Hao Hsu
PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2)
Atlas Genet Cytogenet Oncol Haematol. 2011-04-01
Online version: http://atlasgeneticsoncology.org/gene/41634/pak2
